In 2023, the US import value of cortisone, hydrocortisone, prednisone, and prednisolone was approximately 27.2 million USD. Over the forecasted period from 2024 to 2028, imports are expected to show a slight declining trend from 27.008 million USD in 2024 to 26.356 million USD in 2028, marking an overall decline of approximately 2.4%. Year-on-year variations depict steady decreases, and the five-year CAGR indicates a modest average decline annually, hinting at reduced import reliance or price adjustments.
Future trends to watch include:
- Shifts in global pharmaceutical supply chains impacting import volumes.
- Potential domestic production increases reducing the need for imports.
- Pricing strategies and global demand affecting market dynamics.
